Skeletal Muscle Spasm

• FDA approval · 2024-12-16
  FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for diazepam from Hikma Pharmaceuticals USA Inc., updating the approval status of this generic produ…

• FDA approval · 2023-04-10
  FDA Approved: CHLORZOXAZONE — Original Application (Lifsa Drugs LLC)

  The FDA approved Lifsa Drugs LLC's chlorzoxazone under ANDA214702 as an original application for a generic product.

• FDA approval · 2023-01-11
  FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)

  FDA approved a supplemental application for diazepam (generic) from Natco Pharma USA LLC under ANDA210363.

• FDA approval · 2022-11-10
  FDA Approved: DIAZEPAM — Original Application (Fresenius Kabi USA, LLC)

  The FDA approved Fresenius Kabi USA, LLC's Original Application for diazepam (generic diazepam). This approval adds a new generic option for…

• FDA approval · 2021-03-25
  FDA Approved: DIAZEPAM — Supplemental Application (Oceanside Pharmaceuticals)

  FDA supplemental approval for Diazepam under Oceanside Pharmaceuticals is recorded, confirming the approval of a supplemental application fo…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2021-02-05
  FDA Approved: DIAZEPAM — Supplemental Application (Meridian Medical Technologies LLC)

  The FDA approved a supplemental application for Diazepam submitted by Meridian Medical Technologies LLC.

• FDA approval · 2021-02-05
  FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Diazepam, approving a generic version of the drug.